Jefferies Initiates Coverage On Guardant Health with Buy Rating, Announces Price Target of $32
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Tycho Peterson has initiated coverage on Guardant Health (NASDAQ:GH) with a Buy rating and a price target of $32.
June 03, 2024 | 6:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies has initiated coverage on Guardant Health with a Buy rating and a price target of $32, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $32 by a reputable analyst from Jefferies is likely to boost investor confidence and positively impact the stock price of Guardant Health in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100